Abstract:ObjectiveTo explore the difference in CD4+CD25+Foxp3+T lymphocytes and their secretion of cytokines transforming growth factorβ1(TGFβ1) and interleukin10 (IL10)among drugresistant tuberculosis (DRTB) patients, nondrugresistant tuberculosis(nonDRTB) patients and healthy control subjects, and evaluate its role in the inhibition of specific cellular immune response.MethodsFlow cytometry was applied to detect the expression levels of peripheral blood CD4+CD25+T lymphocytes and CD4+CD25+Foxp3+T lymphocytes in 30 healthy subjects(control group), 39 nonDRTB patients(nonDRTB group) and 35 DRTB patients(DRTB group) ; enzymelinked immunosorbent assay (ELISA) was used to detect TGFβ1 and IL10 levels in peripheral blood in different groups.ResultsCD4+CD25+T and CD4+CD25+Foxp3+T lymphocytes accounted for (17.09±5.43)% and (0.78±0.88)% respectively of total number of CD4+T cells in the peripheral blood of control group, (22.12±3.43)% and (2.79±1.65)% respectively in nonDRTB group, (24.01±5.65)% and (4.51±1.47)% respectively in DRTB group. The percentage of CD25+CD4+T lymphocytes in CD4+T lymphocytes in DRTB group was higher than that of nonDRTB group, but the difference was not significant(P>0.05); the percentage of CD4+CD25+Foxp3+T lymphocytes in CD4+T lymphocytes in DRTB group was significantly higher than control and nonDRTB group (P<0.05), and levels of TGFβ1([4.15±1.39]ρ/ng·L-1) and IL10([872.17±269.75]μg/L) were significantly higher than those of nonDRTB group ([3.03±1.42]ρ/ng·L-1 and [266.83±57.09]μg/L, respectively) as well as control group ([2.12±0.77]ρ/ng·L-1 and [105.21±23.56]μg/L, respectively) (P<0.05).ConclusionCD4+CD25+Foxp3+T lymphocytes may weaken elimination funtion of immune system on Mycobacterium tuberculosis in TB patients,and related to the progress of tuberculosis infection as well as multidrugresistance. TGFβ1 and IL10 may be involved in the inhibition of cellular immunity and have some correlation with the formation and the severity of the DRTB.